NMT Medical To Redesign PFO Trial After Problems With MIST I

NMT Medical will redesign its U.S. pivotal trial for the STARflex patent foramen ovale closure device to treat migraine headaches after its UK trial missed its primary endpoint

More from Archive

More from Medtech Insight